US Revenue Cycle Management (RCM) Market-our new study reveals current trends, technological advancements, and predicted revenues
Where the US Revenue Cycle Management (RCM) market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenue streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 150+ page report provides 150+ tables, 150+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing US Revenue Cycle Management (RCM) market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.
Report Scope
Global US Revenue Cycle Management (RCM) market 2021-2031 is segmented on the basis of Type & End Users.
• Our study discusses the selected leading companies that are the major players in the US Revenue Cycle Management (RCM) by Type:
– Service
–Software
• Our study discusses the selected leading companies that are the major players in the US Revenue Cycle Management (RCM) by End Users:
– Hospitals
– Physician’s Office
–Others
• Our study discusses the selected leading companies that are the major players in the US Revenue Cycle Management (RCM) industry:
– SSI group.
– Allscripts
– Cerner Corporation
– McKesson Corporation
– Athenahealth, Inc.
– EPIC Systems Corporation
– eClinicalWorks
– NextGen Healthcare Information System LLC
– CareCloud Corporation
– Quest Diagnostics, Inc.
–Kareo, Inc
How the US Revenue Cycle Management (RCM) Market report helps you
In summary, our 190+ page report provides you with the following knowledge:
– Revenue forecasts to 2031 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.
– Revenue forecasts to 2031 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the US Revenue Cycle Management (RCM) market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
COVID 19 Impact & Recovery Analysis on the Market
Currently, COVID-19 (Coronavirus) is prevalent across the globe. Many companies are underway to discover a vaccine, or therapeutics which can prevent or cure the COVID-19 virus. According to the World Health Organization, as of 13th September 2020, there were over 28,637,952 confirmed cases of COVID-19, with more than 917,417 deaths, globally.
The COVID-19 disease is continuously disrupting the growth of various markets. However, the immediate effect of the pandemic is different. Some industries will register a drop in demand, various other markets will remain unchanged and display a promising growth opportunities. The healthcare centers, such as hospitals and diagnostic labs, have been investing heavily in maintaining the supply of essential equipment and drugs. Due to lockdown across the globe, people were unable to reach healthcare facilities and non-urgent procedures were advised to put hold which impacted the healthcare industry a lot.
Due to COVID 19 pandemic patients were reluctant in visiting hospitals or clinics for their treatments and preferred virtual doctor visits. Lockdown across the globe due to the pandemic led to the delay of procedures which were not urgent. These factors negatively impacted the revenue cycle management market for limited period of time. However, slowly the situation is getting back to normal everywhere and the market discussed is expected to increase in future.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the US Revenue Cycle Management (RCM) market and leading companies. You will find data, trends and predictions.
The US Revenue Cycle Management (RCM) Market 2021-2031 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the US Revenue Cycle Management (RCM) industry.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today US Revenue Cycle Management Market Report 2021-2031: Forecasts by Product, by Type, by Delivery Mode (Web-based, Cloud-based), by End Use (Physicians’ Office, Hospital). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated VISIONGAIN Reports
1.8. About VISIONGAIN
2. Introduction to the U.S Revenue Cycle Management (RCM) Market
2.1. U.S Revenue Cycle Management (RCM) Market Definition
2.2. Deployment Submarkets Definitions
2.3. Offering Submarkets Definitions
2.4. Function Submarkets Definitions
3. U.S Revenue Cycle Management (RCM) Market Overview
3.1. Global U.S Revenue Cycle Management (RCM) Market Size and Forecast by Region
3.2. Global U.S Revenue Cycle Management (RCM) Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Loss of Revenue Due to Billing Errors
3.3.2. Market Restraints/Challenges
3.3.2.1. Lack of Expert it Specialists
3.3.3. Opportunities
3.3.3.1. Increasing Request for Cloud-Based RCM Explanations
3.3.4. Trends
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weaknesses
3.4.3. Opportunities
3.4.4. Threats
3.5. Porter’s Five Forces Analysis
3.5.1. Competitive Rivalry
3.5.2. Supplier Power
3.5.3. Buyer Power
3.5.4. Threat of Substitution
3.5.5. Threat of New Entry
4. Global U.S Revenue Cycle Management (RCM) Market Analysis and Forecast 2021-2031, by Deployment (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.2. Web-Based
4.3. On-Premise
4.4. Cloud-Based
5. Global U.S Revenue Cycle Management (RCM) Market Analysis and Forecast, 2021-2031 by Offering(Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.2. Software
5.3. Services
6. Global U.S Revenue Cycle Management (RCM) Market Analysis and Forecast, 2021-2031 byFunction (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. Claims & Denial Management
6.3. Medical Coding & Billing
6.4. Patient Insurance Eligibility Verification
6.5. Payment Remittance
6.6. Electronic Health Record (Ehr)
6.7. Clinical Documentation Improvement (Cdi)
6.8. Other Functions
7. North America U.S Revenue Cycle Management (RCM) Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America U.S Revenue Cycle Management (RCM) Market Size and Forecast by Deployment
7.3. North America U.S Revenue Cycle Management (RCM) Market Size and Forecast by Offering
7.4. North America U.S Revenue Cycle Management (RCM) Market Size and Forecast by Function
7.5. U.S Revenue Cycle Management (RCM) Market
7.6. Canada U.S Revenue Cycle Management (RCM) Market
8. Companies in the U.S Revenue Cycle Management (RCM) Market
8.1. The SSI Group, Inc
8.1.1. Company Snapshot
8.1.2. Company Overview
8.1.3. Financial Performance (2015-2019)
8.1.3.1. Net Revenue
8.1.3.2. Gross Profit
8.1.3.3. Geographical Revenue, 2019
8.1.4. Product Offerings
8.1.5. Recent Initiatives (2017-2019)
8.2. Allscripts Healthcare Solutions
8.2.1. Company Snapshot
8.2.2. Company Overview
8.2.3. Financial Performance (2015-2019)
8.2.3.1. Net Revenue
8.2.3.2. Gross Profit
8.2.3.3. Geographical Revenue, 2019
8.2.4. Product Offerings
8.2.5. Recent Initiatives (2017-2019)
8.3. Cerner Corporation
8.3.1. Company Snapshot
8.3.2. Company Overview
8.3.3. Financial Performance (2015-2019)
8.3.3.1. Net Revenue
8.3.3.2. Gross Profit
8.3.3.3. Geographical Revenue, 2019
8.3.4. Product Offerings
8.3.5. Recent Initiatives (2017-2019)
8.4. McKesson Corporation
8.4.1. Company Snapshot
8.4.2. Company Overview
8.4.3. Financial Performance (2015-2019)
8.4.3.1. Net Revenue
8.4.3.2. Gross Profit
8.4.3.3. Geographical Revenue, 2019
8.4.4. Product Offerings
8.4.5. Recent Initiatives (2017-2019)
8.5. athenaHealth, Inc.
8.5.1. Company Snapshot
8.5.2. Company Overview
8.5.3. Financial Performance (2015-2019)
8.5.3.1. Net Revenue
8.5.3.2. Gross Profit
8.5.3.3. Geographical Revenue, 2019
8.5.4. Product Offerings
8.5.5. Recent Initiatives (2017-2019)
8.6. EPIC Systems
8.6.1. Company Snapshot
8.6.2. Company Overview
8.6.3. Financial Performance (2015-2019)
8.6.3.1. Net Revenue
8.6.3.2. Gross Profit
8.6.3.3. Geographical Revenue, 2019
8.6.4. Product Offerings
8.6.5. Recent Initiatives (2017-2019)
8.7. eClinicalWorks LLC
8.7.1. Company Snapshot
8.7.2. Company Overview
8.7.3. Financial Performance (2015-2019)
8.7.3.1. Net Revenue
8.7.3.2. Gross Profit
8.7.3.3. Geographical Revenue, 2019
8.7.4. Product Offerings
8.7.5. Recent Initiatives (2017-2019)
8.8. NextGen Healthcare Information System LLC
8.8.1. Company Snapshot
8.8.2. Company Overview
8.8.3. Financial Performance (2015-2019)
8.8.3.1. Net Revenue
8.8.3.2. Gross Profit
8.8.3.3. Geographical Revenue, 2019
8.8.4. Product Offerings
8.8.5. Recent Initiatives (2017-2019)
8.9. CareCloud
8.9.1. Company Snapshot
8.9.2. Company Overview
8.9.3. Financial Performance (2015-2019)
8.9.3.1. Net Revenue
8.9.3.2. Gross Profit
8.9.3.3. Geographical Revenue, 2019
8.9.4. Product Offerings
8.9.5. Recent Initiatives (2017-2019)
8.10. Other Notable Players
9. Conclusion
10. Glossary
Associated VISIONGAIN Reports
VISIONGAIN Report Sales Order Form
Appendix A
About VISIONGAIN
Appendix B
VISIONGAIN report evaluation form
LIST OF TABLES
Table No 1: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 2: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 3: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 4: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 5: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 6: U.S Revenue Cycle Management (RCM) Market Drivers & Restraints 2020
Table No 7: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 8: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 9: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 10: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 11: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 12: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 13: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 14: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 15: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 16: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 17: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 18: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 19: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 20: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 21: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 22: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 23: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 24: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 25: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 26: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 27: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 28: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 29: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 30: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 31: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 32: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 33: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 34: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 35: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 36: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 37: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 38: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 39: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 40: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 41: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 42: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 43: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 44: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 45: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 46: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 47: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 48: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 49: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 50: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 51: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 52: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 53: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 54: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 55: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 56: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 57: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 58: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 59: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 60: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 61: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 62: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 63: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 64: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 65: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 66: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 67: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 68: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 69: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 70: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 71: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 72: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 73: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 74: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 75: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 76: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 77: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table No 78: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table No 79: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table No 80: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table No 81: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table No 82: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 83: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 84: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 85: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 86: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 87: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 88: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 89: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 90: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 91: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 92: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 93: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 94: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 95: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 96: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 97: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 98: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 99: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 100: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 101: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 102: US U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table No 103: US U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table No 104: US U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table No 105: US U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table No 106: US U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table No 107: The SSI Group, Inc Profile (CEO, HQ, Founded, Website)
Table No 108: The SSI Group, Inc (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 109: The SSI Group, Inc (Net Income 2016-2019 (US$mn, AGR %)
Table No 110: Allscripts Healthcare Solutions Profile (CEO, HQ, Founded, Website)
Table No 111: Allscripts Healthcare Solutions (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 112: Allscripts Healthcare Solutions (Net Income 2016-2019 (US$mn, AGR %)
Table No 113: Cerner Corporation Profile (CEO, HQ, Founded, Website)
Table No 114: Cerner Corporation (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 115: Cerner Corporation (Net Income 2016-2019 (US$mn, AGR %)
Table No 116: McKesson Corporation Profile (CEO, HQ, Founded, Website)
Table No 117: McKesson Corporation (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 118: McKesson Corporation (Net Income 2016-2019 (US$mn, AGR %))
Table No 119: athenaHealth, Inc Profile (CEO, HQ, Founded, Website)
Table No 120: athenaHealth, Inc (Total Company Sales 2016-2019 (US$mn, AGR %)
Table No 121: athenaHealth, Inc (Net Income 2016-2019 (US$mn, AGR %))
Table No 122: EPIC Systems Profile (CEO, HQ, Founded, Website)
Table No 123: EPIC Systems (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 124: EPIC Systems (Net Income 2016-2019 (US$mn, AGR %))
Table No 125: eClinicalWorks LLC. Profile (CEO, HQ, Founded, Website)
Table No 126: eClinicalWorks LLC. (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 127: eClinicalWorks LLC. (Net Income 2016-2019 (US$mn, AGR %))
Table No 128: NextGen Healthcare Information System LLC Profile (CEO, HQ, Founded, Website)
Table No 129: NextGen Healthcare Information System LLC (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 130: NextGen Healthcare Information System LLC (Net Income 2016-2019 (US$mn, AGR %))
Table No 131: CareCloud Profile (CEO, HQ, Founded, Website)
Table No 132: CareCloud (Total Company Sales 2016-2019 (US$mn, AGR %))
Table No 133: CareCloud (Net Income 2016-2019 (US$mn, AGR %))
Table No 134: Other Companies U.S Revenue Cycle Management (RCM) Market 2020 (Company, Location).
LIST OF FIGURES
Figure No 1: U.S Revenue Cycle Management (RCM) Market Deployment Overview
Figure No 2: U.S Revenue Cycle Management (RCM) Market Offeringr Overview
Figure No 3: U.S Revenue Cycle Management (RCM) Market Function Overview
Figure No 4: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure No 5: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure No 6: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure No 7: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure No 8: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure No 9: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 10: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 11: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 12: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 13: U.S Revenue Cycle Management (RCM) Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 14: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 15: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 16: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 17: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 18: Web-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 19: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 20: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 21: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 22: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 23: On-Premise Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 24: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 25: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 26: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 27: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 28: Cloud-Based Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 29: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 30: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 31: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 32: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 33: U.S Revenue Cycle Management (RCM) Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 34: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 35: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 36: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 37: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 38: Software Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 39: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 40: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 41: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 42: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 43: Services Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 44: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 45: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 46: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 47: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 48: U.S Revenue Cycle Management (RCM) Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 49: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 50: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 51: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 52: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 53: Claims & Denial Management Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 54: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 55: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 56: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 57: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 58: Medical Coding & Billing Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 59: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 60: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 61: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 62: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 63: Patient Insurance Eligibility Verification Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 64: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 65: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 66: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 67: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 68: Payment Remittance Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 69: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 70: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 71: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 72: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 73: Electronic Health Record (Ehr) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 74: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 75: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 76: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 77: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 78: Clinical Documentation Improvement (Cdi) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 79: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure No 80: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure No 81: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure No 82: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure No 83: Other Functions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure No 84: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 85: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 86: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 87: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 88: Regional U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 89: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 90: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 91: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 92: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 93: North America U.S Revenue Cycle Management (RCM) Market Forecast by Deployment 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 94: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 95: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 96: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 97: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 98: North America U.S Revenue Cycle Management (RCM) Market Forecast by Offering 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 99: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 100: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 101: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 102: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 103: North America U.S Revenue Cycle Management (RCM) Market Forecast by Function 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 104: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure No 105: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure No 106: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure No 107: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure No 108: U.S Revenue Cycle Management (RCM) Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure No 109: The SSI Group, Inc (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 110: The SSI Group, Inc (Net Income 2016-2019 (US$mn, AGR %)
Figure No 111: Allscripts Healthcare Solutions (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 112: Allscripts Healthcare Solutions (Net Income 2016-2019 (US$mn, AGR %)
Figure No 113: Abbott (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 114: Abbott (Net Income 2016-2019 (US$mn, AGR %)
Figure No 115: McKesson Corporation (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 116: McKesson Corporation (Net Income 2016-2019 (US$mn, AGR %))
Figure No 117: athenaHealth, Inc (Total Company Sales 2016-2019 (US$mn, AGR %)
Figure No 118: athenaHealth, Inc (Net Income 2016-2019 (US$mn, AGR %))
Figure No 119: EPIC Systems (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 120: EPIC Systems (Net Income 2016-2019 (US$mn, AGR %))
Figure No 121: eClinicalWorks LLC. (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 122: eClinicalWorks LLC. (Net Income 2016-2019 (US$mn, AGR %))
Figure No 123: NextGen Healthcare Information System LLC (Total Company Sales 2016-2019 (US$mn, AGR %))
Figure No 124: NextGen Healthcare Information System LLC (Net Income 2016-2019 (US$mn, AGR %))